GlaxoSmithKline and AMREF Celebrate 25 Years of a Vibrant, Dynamic and Robust Partnership

 


On October 29, 2013, AMREF and GSK celebrated a long time partnership spanning over 25 years of working together to create lasting health change in Africa, positively impacting the lives of over 3 million people.


During the celebrations held at the AMREF Dagoretti Child Development and Training Centre, British High Commissioner to Kenya Dr Christian Turner who was the chief guest paid tribute to AMREF and GSK’s work in transforming communities saying, “ In such partnerships what matters to us diplomats and policy makers are the things that work on the ground to build solutions for communities, and we are proud of the phenomenal story that the partnership has had to change the lives of communities.”

Speaking during the event GSK Regional Director John Musunga said: “I have seen our partnership with AMREF grow having made a commitment as GSK to support and improve health care in Africa and we look forward to another 25 years of partnering together.”

GSK’s first corporate support to AMREF was towards a malaria research conducted in 1993, focusing  on communities in Kenya. Later GSK funded the Personal Hygiene and Sanitation Education (PHASE) project, that has to date enabled over 1.5 million children in 16 countries across Africa, Latin America, Asia and Europe adopt and role model sanitation and hygiene practices in their communities

Speaking during the occasion AMREF’s Director General Dr Teguest Guerma reiterated that, PHASE is a very good example of AMREF’s work that begun at community level and has been scaled up at the national level in making a difference in families where children become ambassadors.

GSK through its Positive Action programme has also provided funding and technical support to the Zingatia Maisha project that aims to improve the quality of life of People Living with HIV (PLHIV) in Kenya.

In 2011, GSK set up a new initiative to re-invest back 20% of its profits in 40 least developed countries (LDC) in order to strengthen health systems. Between 2012 and 2013, GSK invested over $10 million to build capacity of frontline health workers where AMREF is the East and Southern Africa partner.

AMREF Kenya Country Director Dr Lennie Kyomuhangi, Samara Hammond CEO AMREF UK, and Grace Wasike from the Ministry of Health were among those who joined the celebrations.